← Back to Search

Procedure

Dry Needling for Scars

N/A

Recruiting

Research Sponsored by Iran University of Medical Sciences

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Age between 20 and 60 years

Be between 18 and 65 years old

Must not have

Fractures that have altered joint mobility

Anticoagulant medication use

Timeline

Screening 3 weeks

Treatment Varies

Follow Up change in pain after the end of 6 treatment sessions compared to baseline and change from baseline at 2-week follow up

Summary

This trial seeks to understand if dry needling can help people with scar tissue, which can limit joint mobility and affect daily activities.

Who is the study for?

This trial is for individuals aged 20-60 with linear hypertrophic scars older than six weeks, without joint movement restrictions near the scar. It's not suitable for those with a fear of needles, diabetes, keloid scars, skin infections near the scar tissue, altered joint mobility due to fractures or those on anticoagulant medications.

What is being tested?

The study tests dry needling's effectiveness on improving flexibility and reducing complications from surgery or trauma-induced linear hypertrophic scars. Participants will receive either true dry needling or sham (fake) treatment to compare outcomes.

What are the potential side effects?

Dry needling may cause discomfort at the needle site, minor bleeding or bruising, temporary soreness in the treated area and less commonly can lead to fatigue after treatment.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 20 and 60 years old.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I have had fractures that changed how my joints move.

Select...

I am taking blood thinner medications.

Select...

I have skin conditions or infections near my scar.

Select...

I have a keloid or immature scar.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ change in health status after the end of 6 treatment sessions compared to baseline and change from baseline at 2-week follow up

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~change in health status after the end of 6 treatment sessions compared to baseline and change from baseline at 2-week follow up

This trial's timeline: 3 weeks for screening, Varies for treatment, and change in health status after the end of 6 treatment sessions compared to baseline and change from baseline at 2-week follow up for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Flexibility of the scar tissue (tissue compliance)

Secondary study objectives

Active and passive joint range of motion

Health-related quality of life

Pain intensity

Trial Design

2Treatment groups

Experimental Treatment

Placebo Group

Group I: True dry needling of the hypertrophic scar tissueExperimental Treatment1 Intervention

Participants with hypertrophic linear scar tissue in the true dry needling group will undergo authentic dry needling interventions targeted at the scar tissue, in conjunction with routine physiotherapy.

Group II: Sham dry needling of the hypertrophic scar tissuePlacebo Group1 Intervention

In the sham dry needling group, participants presenting with hypertrophic linear scar tissue will receive superficial dry needling of the skin, performed at a location distinct from the scar tissue. This will be administered alongside routine physiotherapy.

0 / 5Eligibility criteria met